external reviewer, with expertise in questionnaire design, first evaluated question construction to ensure that it did not contain ..... will need to meet a new statutory requirement for CPD. Optometry's new .... 2014. http://www.drugs.ie/resourcesfi
Apr 2, 2009 - CASE PRESENTATION. A 48-year-old black male was referred to the Glaucoma. Service at the Medical College of Georgia in Augusta 8 days after he was hit in the left eye by an unexploded firework. The patient initially presented to an outs
INTRODUCTION. 6. 2. DEFINITION AND OVERVIEW OF KNOWLEDGE TRANSFER. 7. 3. METHODOLOGY. 8. 3.1. Overview of Interview Respondents. 8. 4. ..... of working). Provide one-on-one guidance, mentoring and coaching to colleagues/ staff. Connect colleagues wit
Conjunctival proinflammatory and proapoproptic effects of latanoprost and ... lash line. The standard evaluation of the ocular surface takes approximately 3 ...
height standard deviation score (SDS), target height, and height relative to target height were analyzed ... The follow-up rate was unrelated to demographics or degree of short stature. .... Turner syndrome was present or diagnosed in 3.4% of.
for detecting and monitoring oligosecretory myeloma, as well as amyloid light chain (AL) amyloidosis. For the initial investigation of monoclonal gammopathy, ...
Jul 12, 2016 - MIBG scans are indicated. The addition of abdominal cross- sectional imaging (computed tomography [CT] or MRI) every two years at the age of 15 years is recommended even in the. Table 1. Recommended assessment and followup of hereditar
UCLA Drug Abuse Research Center/Integrated Substance Abuse Programs, 1640 S. Sepulveda Blvd., Suite 200, Los Angeles 90025, USA. Abstract. Long-term ... likelihood of heavy alcohol use and additional substance abuse treatment among men, whereas women
Jun 20, 2011 - Foerster S, Balzer D, Vincent J, Hellenbrand W, Holzer R,. Cheatham J, Moore J, Lock J, Jenkins K. Adverse event rates in congenital cardiac ...
Apr 3, 2012 - patient chart record analysis was performed on adult AIDS patients enrolled in the treatment program starting from 1 March. 2005. ... morbidity and mortality in people living with HIV [3–7]. .... of followup varied because of different
May 11, 2012 - parotidectomies claim a lower rate of postoperative com- plications for their approach, in particular a lower risk of facial nerve paresis, and point ...
Jul 14, 2014 - Patient residences describing a post office box or rural route, or with missing or ... time along a road network between a patient and their closest ..... Upper Peninsula ... Treatment 2010; 123(1): 233-243. 23. ... Malone KE et al.
531. It is therefore necessary to deal with these barriers in a systematic manner, so that they may ..... Innovation-Scoreboard-2016.pdf (Accessed in 11/03/2017).
Dec 15, 2015 - training and education, confidentiality, and asses- sing a limited number ... the implementation of CQI programs in colonoscopy services. This type of ... We performed standardized literature searches on 15 relevant databases ...
Keywords: Human rationality and its scope; GÃ¶del's theorem; Computational complexity; Chaotic behavior; Cellular ... in our understanding of the behavior of complex dynamic systems have dissolved neoclassicism's very .... classes of problems, the mo
Sep 11, 2010 - Traditional views regarding marriage and family life may also be affirmed in informal settings ... of prayer will be inversely associated with barriers to marriage ..... (2.54 on a 4-point scale); however, both African American and ...
improvements in activities of daily living and hospital length ..... Incontinent patients receiving CLRT should have diapers and specially designed pads.
author has found that latanoprost, travoprost, and bimato- prost all cause children to grow impressively long and thick eyelashes. For patients receiving ...
ber, a 1.7-mm layered hyphema, a patent su- perior iridectomy, and a dense nuclear scle- rotic cataract (Figure 1). Nylon sutures from the surgical iridectomy were visible superior- ly at the limbus. The slit-lamp examination of her left eye revealed
Jï¼ Rigby Slight, MD, Associate Clinical Profes- ... his laboratory is expanding refining existing models ... Rigby Slight, MD (Figure 10), Associate Profes- sor, is a ...
Apr 29, 2016 - 1 Road Traffic Injury Research Center and Department of Health Services ... communication barriers in the process of patient transfer. ..... The methods include a manual or electronic record system of complaints in order to ...
(n=1418). Articles included in review. (n=17). Full-text articles assessed for eligibility. (n=59). Full-text articles excluded: Quantitative (n=1). Pre-implementation ...
Jun 8, 2016 - Glaucoma is a disease of the optic nerve, which carries visual signals ..... SQSTM1 in NTG pathogenesis by testing a large cohort of NTG ...
no effective screening methods for the disease and sur- geons do not know .... choroidal expansion (referred to as effusion) in eyes with primary ACG.37,38.
Patient-Related and System-Related Barriers to Glaucoma Follow-up in a County Hospital Population Bradford W. Lee,1 Yohko Murakami,1 Martin T. Duncan,1 Andrew A. Kao,2 Jehn-Yu Huang,2 Shan Lin,2 and Kuldev Singh1 1 2
Department of Ophthalmology, Stanford University School of Medicine, Stanford, California Department of Ophthalmology, University of California, San Francisco, San Francisco, California
Correspondence: Shan Lin, University of California, San Francisco, 10 Koret Way, Room K-325, San Francisco, CA 94143-0730; [email protected] Submitted: March 26, 2013 Accepted: July 29, 2013 Citation: Lee BW, Murakami Y, Duncan MT, et al. Patient-related and systemrelated barriers to glaucoma follow-up in a county hospital population. Invest Ophthalmol Vis Sci. 2013;54:6542– 6548. DOI:10.1167/iovs.13-12108
PURPOSE. To identify the barriers to glaucoma follow-up and to assess how ethnicity influences the effect of such barriers among patients in a county hospital population. METHODS. This cross-sectional study included 152 patients, 76 with poor clinic follow-up and 76 with good clinic follow-up, who were recruited at the San Francisco General Hospital glaucoma clinic as part of a case-control study. All subjects were required to be established patients with glaucoma initially seen and diagnosed in the clinic at least 1 year before enrollment. An oral questionnaire pertaining to the barriers to follow-up for glaucoma, as well as patient ethnicity, was administered to all participating subjects. The main outcome measure was the prevalence of significant barriers to follow-up, both overall and stratified by ethnicity. RESULTS. The most prevalent barriers to follow-up included long clinic waiting times (75%), appointment scheduling difficulties (38%), the effect of other medical or physical comorbidities (29%), and difficulties related to medical interpretation (23%). While several barriers were cited as being important across different ethnicities, Latinos and Asian–Pacific Islanders were particularly affected by difficulties related to medical interpretation (P ¼ 0.0001) and long waiting times in the clinic (P ¼ 0.048). CONCLUSIONS. Understanding patient-reported barriers to glaucoma follow-up and their variation based on ethnicity may give providers insight as to why patients do not adhere to follow-up recommendations. Strategies to improve follow-up may include reduced clinic wait times, simplified appointment scheduling, and provision of appropriate education and counseling regardless of the patient’s native language and ethnicity. Keywords: clinical follow-up, barriers to follow-up, ethnicity, compliance
laucoma is a leading cause of blindness in the United States and globally,1,2 with a US prevalence that is expected to increase more than 50% between 2000 and 2020 in large part due to an aging population.3 Prospective randomized clinical trials have validated the efficacy of medications and surgical interventions to lower IOP and slow glaucomatous vision loss.4–9 However, the lack of an ideal surgical procedure, as well as problems with adherence to medication use and clinical follow-up, makes glaucoma care a challenge both in developing and developed countries. Numerous studies10–15 have demonstrated poor patient adherence to glaucoma medication regimens, but relatively little is known about the problem of poor clinic follow-up among existing patients with glaucoma. Kosoko et al.16 anecdotally reported several primary reasons for poor followup in an inner-city glaucoma clinic in Baltimore, Maryland, including the costs of glaucoma care, the perception that this disease was ‘‘not serious enough,’’ and dissatisfaction with waiting times. Lee et al.,17 in a study at the Aravind Eye Care System in South India, found that the most prevalent patientreported barriers to glaucoma follow-up were the patients’ belief that they had no problem with their eyes, the lack of an escort to assist patients in attending the clinic, and inability to be absent from work responsibilities.
There is considerable interest in the glaucoma community on how glaucoma affects populations of different races. Several large epidemiologic studies18–21 have clearly demonstrated that race influences glaucoma prevalence, with African Americans and Latinos being at particularly high risk of having the disease. However, less is known about how race and ethnicity affect glaucoma care within a multiethnic population. The report by the Institute of Medicine of the National Academies on racial and ethnic disparities in health care suggests that several minority groups receive poor-quality health care compared with nonminorities residing in the United States; furthermore, minority groups may face a range of complex barriers relating to access to care, language, provider bias, or other patient-level or health care system factors.22 No studies, to our knowledge, have examined the barriers to glaucoma follow-up in a multiethnic population and the ways such barriers may differentially affect specific ethnic groups. Regular follow-up in the clinic is generally considered important in maximizing the likelihood of visual preservation in those with glaucoma. Glaucomatous disease varies tremendously between individuals with regard to severity and rate of progression, and regular follow-up allows the practitioner to adjust therapy based on the disease course. A greater understanding of the barriers to follow-up from the patient’s
Copyright 2013 The Association for Research in Vision and Ophthalmology, Inc. www.iovs.org j ISSN: 1552-5783
IOVS j October 2013 j Vol. 54 j No. 10 j 6543
Barriers to Glaucoma Follow-up in County Hospital
TABLE 1. Criteria for Classifying Cases and Controls Based on Follow-up During the 12 to 18 Months Preceding the Study* Glaucoma Disease Severity† Variable Follow-up recommendations‡ Good follow-up (controls)
Poor follow-up (cases)
Mild Every 5–6 mo (approximately 2 visits per year) ‡2 Visits per year, with 5–6 mo maximum intervals between visits 1 Visit per year or extended interval between visits
Moderate Every 4–5 mo (approximately 3 visits per year) ‡3 Visits per year, with 4–5 mo maximum intervals between visits 2 Visits per year or extended interval between visits
Severe Every 3–4 mo (approximately 4 visits per year) ‡3 Visits per year, with 3–4 mo maximum intervals between visits 2 Visits per year or extended interval between visits
* Because of the unpredictability of patient follow-up patterns and the need for clinical judgment in evaluating good versus poor follow-up, two members of the research team (BWL, YM) independently evaluated each subject’s follow-up status based on actual and advised follow-up dates. Any discrepancies in classification were then discussed until a consensus was reached to ensure standardized classification of follow-up status. † Glaucoma disease severity was evaluated based on the American Academy of Ophthalmology Preferred Practice Pattern guidelines for primary open-angle glaucoma and suspected disease. In mild disease, characteristic optic nerve abnormalities are consistent with glaucoma, but the visual field is normal. In moderate disease, visual field abnormalities exist in one hemifield and are not within central 58 of fixation. In severe disease, visual field abnormalities exist in both hemifields, or visual field loss is within central 58 of fixation. ‡ Recommended follow-up intervals at the SFGH glaucoma clinic were based on disease severity as outlined in the American Academy of Ophthalmology Preferred Practice Pattern guidelines.
perspective would allow eye care providers to develop targeted strategies to eliminate obstacles to clinic follow-up. This study aimed to identify the most significant barriers to follow-up in a multiethnic population of patients with glaucoma attending an urban county hospital clinic in the United States.
METHODS This cross-sectional study included 76 patients having glaucoma with poor clinic follow-up and 76 patients having glaucoma with good clinic follow-up who were recruited during a 6month period in 2008–2009 as part of a case-control study at the San Francisco General Hospital (SFGH) glaucoma clinic. The clinic is situated at an urban publicly owned county hospital that provides comprehensive health care services and acts as a safety net for San Francisco’s poor, uninsured, homeless, and immigrant populations. The clinic is staffed by resident and attending physicians from the University of California, San Francisco. All subjects were classified either as cases (those with poor follow-up) or controls (those with good follow-up). This classification was based on adherence to follow-up regimens generally recommended for patients at the SFGH depending primarily on disease severity and control (Table 1). For all subjects, glaucoma follow-up visits at the SFGH during the period 12 to 18 months before the commencement of the study were ascertained from documentation in their medical records. Subjects deemed to have good follow-up were those who attended follow-up visits within a certain maximum interval between visits as advised by their ophthalmologist. Disease severity for each subject was assessed by a senior glaucoma specialist (J-YH, SL) according to the American Academy of Ophthalmology Preferred Practice Pattern guidelines for primary open-angle glaucoma23 and was based on the subject’s most recent ophthalmological examination, including optic nerve and visual field characteristics. Subject eligibility criteria included the following: (1) establishment of care at the SFGH glaucoma clinic at least 1 year before study commencement as ascertained by review of the medical record, (2) age 40 years or older, and (3) a diagnosis of primary open-angle glaucoma, angle-closure glaucoma, normal tension glaucoma, pigmentary and/or exfoliative glaucoma, or ocular hypertension. All eligible patients attending follow-up visits in the glaucoma clinic were
approached regarding enrollment in the study whenever a member of the multilingual research team (BWL, YM, MTD, AAK) was available to conduct oral questionnaires. After obtaining informed consent, subjects were asked whether they were proficient in English. The standardized questionnaires were administered orally in the subject’s preferred language (English, Spanish, Mandarin, Cantonese, Vietnamese, or Tagalog) by a member of the multilingual research team. Data were collected on race and ethnicity, as well as on other factors such as transportation to the clinic, monetary cost of medications and follow-up clinic visits, medication use, knowledge about glaucoma, and perceptions regarding the difficulty and importance of attending glaucoma follow-up examinations. All subjects were then asked specifically whether any of 16 potential barriers posed ‘‘significant barriers’’ to attending glaucoma follow-up during the past year. They were also asked to cite any additional barriers, as well as the single most important barrier, where applicable. Before formal commencement of the study, a pilot study was conducted with 14 patients meeting the eligibility criteria to validate the questionnaire, develop coding classifications, and test the questionnaire’s feasibility and acceptability. The study protocol was approved by the institutional review boards of the collaborating institutions (the Stanford University School of Medicine, the SFGH, and the University of California, San Francisco). This research project adhered to the tenets of the Declaration of Helsinki and maintained Health Insurance Portability and Accountability Act of 1996 compliance at all times. Statistical analysis was performed using a commercially available software package (SPSS 18.0; SPSS, Chicago, IL). The prevalence of various barriers to follow-up was calculated for the aggregate study population and was also stratified by race as part of a prospectively planned analysis. The v2 test was used to determine whether certain barriers disproportionately affected specific ethnic groups.
RESULTS Demographic characteristics of patients with inconsistent follow-up (cases) and consistent follow-up (controls) are summarized in Table 2. Of 170 patients recruited for the study, 14 were involved in the pilot study, and four declined to participate, citing time constraints. The remaining 152 subjects completed the oral questionnaire and were included in the
IOVS j October 2013 j Vol. 54 j No. 10 j 6544
Barriers to Glaucoma Follow-up in County Hospital TABLE 2. Demographic Characteristics of the Study Population Variable
Overall, n ¼ 152
Cases, n ¼ 76
Controls, n ¼ 76
Age, y Mean (SD) Group, n (%) 40–49 50–59 60–69 70–79 ‡80
8 34 69 33 8
(5.3) (22.4) (45.4) (21.7) (5.3)
4 19 36 12 5
(5.3) (25.0) (47.3) (15.8) (6.6)
4 15 33 21 3
(5.3) (19.7) (43.4) (27.6) (3.9)
Sex, n (%) Female Male
0.24 96 (63.2) 56 (36.8)
44 (57.9) 32 (42.1)
52 (68.4) 24 (31.6)
19 34 41 57
6 21 18 31
13 13 24 26
Race/ethnicity, n (%) White Black Asian–Pacific Islander Latino
(12.5) (22.4) (27.0) (37.5)
(7.9) (27.6) (23.7) (40.8)
(17.1) (17.1) (31.6) (34.2)
English proficiency, n (%) Yes No
0.87 80 (52.6) 72 (47.4)
39 (51.3) 37 (48.7)
41 (53.9) 35 (46.1)
53 54 24 13 8
29 29 10 5 3
24 25 14 8 5
Primary language, n (%) English Spanish Mandarin/Cantonese Tagalog Other
0.62 (34.9) (35.5) (15.8) (8.6) (5.3)
(38.2) (38.2) (13.2) (6.6) (3.9)
(31.6) (32.9) (18.4) (10.5) (6.6)
Level of education, n (%) College and beyond Secondary school Grade school or less
0.93 48 (31.6) 40 (26.3) 64 (42.1)
25 (32.9) 18 (23.7) 33 (43.4)
23 (30.3) 22 (28.9) 31 (40.8)
61 (40.1) 33 (21.7) 58 (38.2)
25 (32.9) 18 (23.7) 33 (43.4)
36 (47.3) 15 (19.7) 25 (32.9)
139 (91.4) 13 (8.6)
67 (88.2) 9 (11.8)
72 (94.7) 4 (5.3)
111 (73.0) 41 (27.0)
55 (72.4) 21 (27.6)
56 (73.7) 20 (26.3)
Disease severity, n (%) Mild Moderate Severe
Outside service utilization, n (%) Seen only at SFGH for glaucoma-related care Seen outside of SFGH
Employment status, n (%) Not employed/retired Employed
Health insurance status, n (%) Government coverage (Medicare, MediCal, San Francisco Health Plan) Private None
Reference OR, 3.50 (95% CI, 1.07–11.5), P ¼ 0.04 OR, 1.63 (95% CI, 0.52–5.10), P ¼ 0.41 OR, 2.58 (95% CI, 0.86–7.75), P ¼ 0.09
0.18 143 (94.1) 7 (4.6) 2 (1.3)
69 (90.8) 5 (6.6) 2 (2.6)
74 (97.4) 2 (2.6) 0
CI, confidence interval; OR, odds ratio. * Calculated by the Fisher exact test. P values for race/ethnicity were calculated based on unadjusted ORs for poor follow-up.
final analysis according to the case-control protocol. Latino subjects represented the largest racial/ethnic subgroup, followed by Asian–Pacific Islanders (APIs), blacks, and whites. The mean age and severity of glaucoma did not differ substantially across ethnicities within the study. There was, however, a preponderance of men comprising the white subject group, while approximately two-thirds of black, Latino, and API subjects were female. All white and black subjects were proficient in English, whereas roughly 60% to 80% of Latino and API subjects reported a lack of proficiency in
English and thus required the assistance of a foreign language medical interpreter. Black race was associated with poor follow-up on univariate analysis (P ¼ 0.04), as has been previously reported by Murakami et al.24 Among the 152 subjects in the study, 132 (87%) reported having at least one significant barrier to follow-up. Patientreported barriers to follow-up are shown in Figure 1. The most prevalent barriers were long waiting times in the clinic (75%), appointment scheduling difficulties (38%), the effect of other medical or physical conditions (29%), and difficulties related to
IOVS j October 2013 j Vol. 54 j No. 10 j 6545
Barriers to Glaucoma Follow-up in County Hospital
FIGURE 1. Patient-reported barriers to follow-up in an urban county hospital population in San Francisco.
medical interpretation (23%). Subjects reported waiting an average of 2.3 hours when attending the clinic for glaucoma follow-up examinations. Appointment scheduling difficulties included delayed appointment availability, rescheduling of confirmed appointments by clinic staff, and inability to communicate with schedulers because of the subject’s lack of English proficiency. The medical and physical conditions found to be the most prominent barriers to follow-up were those limiting mobility, including joint disease. Our definition of ‘‘difficulties related to interpretation’’ applied only to subjects utilizing foreign language medical interpreters, and these difficulties included additional waiting times for interpreters to arrive in the clinic and a sense that the interpreterassisted physician-patient discussions still resulted in inadequate comprehension of their condition, treatment, and prognosis. Figure 1 also shows the single barrier deemed most important by those study subjects citing at least one significant barrier to follow-up. Long waiting times in the clinic (27%), other medical or physical conditions (15%), difficulties related to interpretation (14%), and appointment scheduling difficulties (13%) were reported to be the most important barriers. Because all subjects were recruited as part of a related casecontrol study, univariate and multivariate logistic regression analyses were performed for each potential barrier to follow-up in an effort to determine whether a particular barrier was independently predictive of good versus poor follow-up. None of the barriers were found to be statistically significant in predicting poor versus good follow-up in this particular analysis. Data on the barriers to follow-up were analyzed by race and ethnicity as part of a prospectively planned subgroup analysis (Fig. 2). Responses were remarkably similar across different ethnic groups with regard to which barrier was considered most important. All ethnicities reported long waiting times among their most important barriers to follow-up, with three out of four ethnic groups citing this factor as being most important. The exception was in the Latino group, among whom difficulties relating to interpretation ranked as the most important barrier to follow-up. Difficulties with interpretation were also reported to be important in the API group, ranking second only to waiting times, but were not ranked within the top three for the white and black groups, undoubtedly because
subjects in the latter groups were more commonly fluent in English than those in the Latino and API groups. Table 3 summarizes all reported barriers to follow-up among the four ethnic groups. The problem of long waiting times in the clinic and difficulties related to interpretation varied significantly among different ethnic groups. While the data suggested that cost of care may be a more important barrier for the API group relative to the other groups, this finding did not achieve statistical significance in our study population.
DISCUSSION The field of glaucoma research has devoted much attention to demonstrating the efficacy of various medical, laser, and surgical interventions that lower IOP and can slow glaucomatous visual loss. Glaucoma medication noncompliance has likewise been the subject of intensive investigation given the assumed importance of administering prescribed therapy to slow disease progression. In contrast, there has been a dearth of research regarding the problem of poor patient adherence to recommended glaucoma follow-up, an issue that is undoubtedly important in providing quality glaucoma care for individuals and populations. Without proper glaucoma follow-up, providers cannot monitor treatment efficacy and adverse effects, create individualized therapeutic regimens, or offer continual counseling and education to patients about their disease. Predictors of poor follow-up in our study population are reported separately24 and can assist the clinician in predicting which patients may be at risk of nonadherence with glaucoma follow-up. The present analysis focused on better understanding the barriers to follow-up from the patient’s perspective, a necessary step in facilitating adherence to follow-up. The Los Angeles Latino Eye Study25–27 reported on eye care utilization patterns among a southern California Latino population in which subjects were identified via populationbased eye screenings and subsequently sought formal care per health care provider recommendations. In contrast, our multiethnic study population was identified in an urban glaucoma clinic and then assessed with regard to adherence to recommended clinic follow-up. In our study, the four most significant barriers to follow-up, assessed both in terms of
IOVS j October 2013 j Vol. 54 j No. 10 j 6546
Barriers to Glaucoma Follow-up in County Hospital
FIGURE 2. Most important barrier to follow-up by race in an urban county hospital population in San Francisco.
overall prevalence and by the single most important barrier to follow-up, were the following: (1) long waiting times in the clinic, (2) appointment scheduling difficulties, (3) other medical or physical conditions, and (4) difficulties related to interpretation. Among these top four, the first three were universally problematic across all ethnic groups. Waiting time was found to be the single most important barrier to follow-up, and among those reporting this as a significant barrier, the average reported waiting time was 2.3 hours (range, 1–6 hours). These waiting times were patient reported and were not confirmed by the research team. The
estimates, however, were confirmed to be reasonable when clinic staff were informally interviewed regarding this matter during the course of the study. One contributing factor to long waiting times may have been an overabundance of patients with glaucoma relative to glaucoma physicians, a problem that is widespread across the United States and particularly worse in medically underserved areas and in developing countries. Other factors that prolong waiting times include the frequent need to use interpreters for patients lacking English proficiency and the fact that certain patients may need to be evaluated by both a resident and an attending ophthalmologist.
TABLE 3. All Reported Barriers to Follow-up Based on Ethnicity Subjects Reporting Specific Barrier, n (%) Barrier
White, n ¼ 19
Black, n ¼ 34
Long waiting times in clinic Appointment scheduling difficulties Other medical or physical conditions Difficulties related to interpretation Forgot appointment Financial costs Unable to leave work responsibilities Lack of escort Other serious personal matters Other incidental obligations Security concerns when coming to clinic Lost wages ‘‘My eyes were okay at the time’’ Unaware of the importance of regular follow-up
Barriers to Glaucoma Follow-up in County Hospital Difficulty with appointment scheduling was the second most commonly cited reason for poor follow-up, with limiting factors ranging from a lack of availability of follow-up appointments at the recommended interval to inability of the patient to communicate with appointment schedulers who lacked proficiency in the language spoken by the patient. Strategies to mitigate the latter problem might include hiring appointment schedulers with basic proficiency in the most commonly spoken languages among patients in the clinic and using interpreter services for patient scheduling when needed. Medical and physical conditions posed a significant barrier to follow-up for many subjects, with the most common causes being lower extremity joint pain, limited mobility, and poor vision. A previous report from India by Lee et al.17 similarly revealed that patients viewed their other nonocular medical and physical comorbidities as important barriers to follow-up for glaucoma but that this effect was diminished by the custom of having family members accompany patients to the clinic. Difficulties related to interpretation differentially affected Latino and API subjects, who viewed this as the single most and second most important barriers to follow-up, respectively. English proficiency, surprisingly, was not found to correlate with the likelihood of keeping scheduled appointments, which concurred with the results of another study28 assessing followup for breast abnormalities in minority, low-income patients in Los Angeles. These findings are consistent with the possibility that patients lacking English proficiency, while able to attend follow-up appointments, are perhaps affected with regard to the quality of care received if difficulties with interpretation result in unanswered questions about glaucomatous disease, its prognosis, or the rationale behind attending regular follow-up examinations. Each of these hypotheses warrants further study. One limitation of this study was that the study population was drawn from a very specific practice environment (an urban, county, university-affiliated teaching hospital). There are particular limitations and constraints imposed by this practice environment; thus, our findings may not be generalizable to other glaucoma populations. The study also had a somewhat modest sample size, especially for the subgroup analysis that partitioned the study population into racial subgroups. The study was not powered to specifically address the question of differential barriers by race. Thus, while the sample size was adequate to assess our primary study goal of determining the barriers to follow-up, caution must be used in attempting to generalize our findings regarding race to other populations. Further confirmatory studies are needed that are specifically powered to address this question. To process the ramifications of this study’s findings from a health system perspective, one must consider which barriers are system related and thus modifiable at the clinic and hospital levels versus those which are patient related, with the latter being less amenable to intervention by practitioners delivering health care. Of the four most significant barriers to follow-up, three (long waiting times in the clinic, appointment scheduling difficulties, and difficulties related to interpretation) are indeed system related, whereas only one (other medical or physical conditions) is patient related. Health care providers in medically underserved settings may ascribe poor glaucoma follow-up primarily to patient-related barriers, but the results of our study suggest that patients may find system-related barriers to be of paramount importance. Every eye care provider operates in a unique practice environment with regard to physical resources, staff, and patient population. While one must thus exert caution in generalizing this study’s conclusions to other urban multiethnic glaucoma practices, our findings suggest that providers should at least consider, if not systematically seek to understand, the patient-related and system-related barriers to
follow-up experienced by patients. Although individual barriers to follow-up did not ultimately predict who did and did not follow up as advised, these barriers certainly have implications in terms of quality and equitability of care provided. Our study underscores how different barriers to follow-up may be borne disproportionately by certain ethnic groups. Future studies are needed to assist in developing interventions that can reduce system-related barriers to follow-up, ensure equitable glaucoma care delivery regardless of language or ethnicity, and ultimately determine whether reducing patient-reported barriers translates into improved clinical follow-up and outcomes.
Acknowledgments Supported by the Stanford University Medical Scholars Research Program (BWL, YM). Disclosure: B.W. Lee, None; Y. Murakami, None; M.T. Duncan, None; A.A. Kao, None; J.-Y. Huang, None; S. Lin, None; K. Singh, None
References 1. Congdon N, O’Colmain B, Klayer CC, et al.; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477–485. 2. Giangiacomo AC, Coleman AL. The epidemiology of glaucoma. In: Grehn F, Stamper R, eds. Glaucoma. Berlin-Heidelberg: Springer; 2009:13–21. 3. Friedman DS, Wolfs RC, O’Colmain BJ, et al.; Eye Diseases Prevalence Research Group. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004; 122:532–538. 4. Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M; Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268– 1279. 5. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E; Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121:48–56. 6. Lichter PR, Musch DC, Gillespie BW, et al.; CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study (CIGTS) comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943–1953. 7. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–713. 8. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z; EMGT Group. Predictors of long-term progression in the Early Manifest Glaucoma Trial. Ophthalmology. 2007;114:1965– 1972. 9. Kass MA, Gordon MO, Hoff MR, et al. Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals: a randomized, doublemasked, long-term clinical trial. Arch Ophthalmol. 1989;107: 1590–1598. 10. Friedman DS, Quigley HA, Gelb L, et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistence Study (GAPS). Invest Ophthalmol Vis Sci. 2007;48:5052–5057. 11. Tsai T, Robin AL, Smith JP III. An evaluation of how glaucoma patients use topical medications: a pilot study. Trans Am Ophthalmol Soc. 2007;105:29–35.
IOVS j October 2013 j Vol. 54 j No. 10 j 6548
Barriers to Glaucoma Follow-up in County Hospital 12. Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007;144: 533–540. 13. Sleath B, Robin AL, Covert D, Byrd JE, Tudor G, Svarstad B. Patient-reported behavior and problems in using glaucoma medications. Ophthalmology. 2006;113:431–436. 14. Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140:598–606. 15. Ngan R, Lam DL, Mudumbai RC, Chen PP. Risk factors for noncompliance with follow-up among normal-tension glaucoma suspects. Am J Ophthalmol. 2007;144:310–311. 16. Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM. Risk factors for noncompliance with glaucoma follow-up visits in a residents’ eye clinic. Ophthalmology. 1998;105: 2105–2111. 17. Lee BW, Sathyan P, John RK, Singh K, Robin AL. Predictors of and barriers associated with poor follow-up in patients with glaucoma in South India. Arch Ophthalmol. 2008;126:1448– 1454. 18. Sommer A, Tielsch JM, Katz J, et al. Baltimore Eye Survey Research Group. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey. Arch Ophthalmol. 1991; 109:1090–1095. 19. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma: the Baltimore Eye Survey. JAMA. 1991;266:369– 374. 20. Quigley HA, West SK, Rodriguez J, Munoz B, Klein R, Snyder R. The prevalence of glaucoma in a population-based study of
Hispanic subjects: Proyecto VER. Arch Ophthalmol. 2001;119: 1819–1826. Varma R, Ying-Lai M, Francis BA, et al.; Los Angeles Latino Eye Study Group. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111:1439–1448. Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2003. American Academy of Ophthalmology. Primary Open-Angle Glaucoma: Preferred Practice Pattern. San Francisco: American Academy of Ophthalmology; 2005. Murakami Y, Lee BW, Duncan M, et al. Racial and ethnic disparities in adherence to glaucoma follow-up visits in a county hospital population. Arch Ophthalmol. 2011;129:872– 878. Unzueta M, Globe D, Wu J, Paz S, Azen S, Varma R; Los Angeles Latino Eye Study Group. Compliance with recommendations for follow-up care in Latinos: the Los Angeles Latino Eye Study. Ethn Dis. 2004;14:285–291. Paz, SH, Varma R, Klein R, Wu J, Azen SP; Los Angeles Latino Eye Study Group. Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino Eye Study. Ophthalmology. 2006;113:1372–1377. Morales LS, Varma R, Paz SH, et al; Los Angeles Latino Eye Study Group. Self-reported use of eye care among Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2010;117:207– 215. Kaplan CP, Eisenberg M, Erickson PI, Crane LA, Duffey S. Barriers to breast abnormality follow-up: minority, low-income patients’ and their providers’ view. Ethn Dis. 2005;15:720– 726.